Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-01-24Clinical Trial Update: The Effect Of Aromatherapy Applied To Children Aged 9-12 On Exam Anxiety, Attention Deficit and Academic Success [NA]
A clinical trial exploring whether aromatherapy for children aged 9-12 impacts exam anxiety, attention deficits, and academic achievement.
-
FDA approval · 2025-01-23FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved a supplemental application for lisdexamfetamine dimesylate from Camber Pharmaceuticals, enabling its generic product to be …
-
FDA approval · 2025-01-23FDA Approved: QELBREE — Supplemental Application (Supernus Pharmaceuticals, Inc)
The FDA approved a supplemental application for QELBREE (viloxazine hydrochloride) from Supernus Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: The Effect of Attention on Postural Control
The clinical trial investigating the effect of attention on postural control in individuals with ADHD has completed.
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: Pai.ACT - An Artificial Intelligence Driven Chatbot Assisted ACT (Full Scale RCT) [NA]
Clinical trial update for Pai.ACT, an artificial intelligence–driven chatbot-assisted ACT trial for neurodevelopmental disorders, including …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: Cognitive-Behavioral Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in College Students - Study 1 [NA]
A completed clinical trial evaluating cognitive-behavioral treatment for ADHD in college students (Study 1). The document notes the status i…
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: Pai.ACT - An Artificial Intelligence Driven Chatbot Assisted ACT [NA]
Clinical trial update indicates that Pai.ACT, an AI-driven chatbot supporting ACT-based therapy, is currently recruiting participants for au…
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: Impact of Stimulants and In-Scanner Motion on Attentive Task Performance in ADHD (ADHD_NFB)
Clinical trial update investigating the impact of stimulant medications and in-scanner motion on attentive task performance in ADHD; the stu…
-
CLINICAL_TRIALS research · 2025-01-16Clinical Trial Update: Optimizing Research With Diverse Families - Feasibility and Acceptability Study (FAST) [NA]
This feasibility and acceptability study (FAST) at Oregon Health & Science University is recruiting to optimize research with diverse famili…
-
FDA approval · 2025-01-15FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for a generic dexmethylphenidate hydrochloride product from Camber Pharmaceuticals, expanding its re…
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: Remote School-Home Program to Improve Youth Attention and Behavior in Mexican Students [NA]
A completed clinical trial evaluated a remote school-home program to improve attention and behavior in youth with ADHD and Oppositional Defi…
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: Evaluating Treatment of ADHD in Children with Down Syndrome [Phase 4]
A Phase 4 clinical trial sponsored by Children’s Hospital Medical Center in Cincinnati is recruiting to evaluate treatment of ADHD in childr…
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: Association Between Motor Skills and Sensory Profiles in Children With Typical and Atypical Development Aged 4 to 11 Years
A recruiting study at University of Vic - Central University of Catalonia is examining the relationship between motor skills and sensory pro…
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: Feasibility/Acceptability of Attentional-Control Training in Survivors [NA]
A clinical trial is evaluating the feasibility and acceptability of attentional-control training in survivors of pediatric cancer, currently…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Personalized Attention-Deficit/Hyperactivity Disorder (ADHD) Medication Experiment Study [NA]
This clinical trial update shows an active, not recruiting ADHD study sponsored by Children's Hospital Medical Center, Cincinnati. No result…
-
CLINICAL_TRIALS trial_result · 2025-01-03Clinical Trial Update: Performance and FMRI BOLD Signal Changes in Impulsive Patients
This update describes a completed study evaluating performance and FMRI BOLD signal changes in impulsive patients with ADHD and borderline p…
-
CLINICAL_TRIALS trial_result · 2024-12-31Clinical Trial Update: Effects of Exercise Intensity on ADHD Symptoms [NA]
A Kent State University clinical trial evaluated how different exercise intensities affect symptoms of attention-deficit/hyperactivity disor…
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: An Adjunct Study to Assess Guided ADHD Therapy for Managing the Extent and Severity of Symptoms [NA]
An adjunct study evaluating guided ADHD therapy to manage symptom extent and severity is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD)
The National Human Genome Research Institute completed a genetic analysis study on Attention-Deficit/Hyperactivity Disorder. It investigated…
-
FDA approval · 2024-12-23FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (Method Pharmaceuticals, LLC)
FDA approved a supplemental application for clonidine hydrochloride submitted by Method Pharmaceuticals, LLC.
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: fNIRS-Based Neurofeedback Training in Children With ADHD: The Effects of VR [NA]
The University of Hong Kong is conducting a recruiting study evaluating fNIRS-based neurofeedback training with virtual reality for children…
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: Assessment of Handwriting Skills in a Sample of Egyptian Children with Attention-Deficit Hyperactivity Disorder
A completed clinical trial evaluating handwriting skills in Egyptian children diagnosed with attention-deficit/hyperactivity disorder.
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: Biomarkers of ADHD Treatment Response [Phase 1]
A Phase 1 trial at Boston Children's Hospital is investigating biomarkers that predict response to ADHD treatment, and the study has complet…
-
FDA approval · 2024-12-17FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Supplemental Application (Teva Pharmaceuticals, Inc.)
FDA approved a Teva supplemental application for a generic combination of four amphetamine salts (dextroamphetamine saccharate, amphetamine …
-
FDA approval · 2024-12-17FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for Dexmethylphenidate hydrochloride (Amneal) to approve a generic version of the ADHD medication.